Seo, K., Rainer, P.P., Shalkey, H.V., Lee, D.I., Jo, S.H. and Andersen, A. (2014) Combined TRPC3 and TRPC6 Blockade by Selective Small-Molecule or Genetic Deletion Inhibits Pathological Cardiac Hypertrophy. Proceedings of the National Academy of Sciences of the United States of America, 111, 1551-1556.
http://www.ncbi.nlm.nih.gov/pubmed/24453217

has been cited by the following article:

• TITLE: TRPC3 and TRPC6 Contribute to the Pathogenesis of Hypertension

  AUTHORS: Qin Zou, Cui Zhang, Yuqing Guo

  KEYWORDS: TRPC3, TRPC6, Hypertension, Calcium

  JOURNAL NAME: American Journal of Molecular Biology, Vol.5 No.4, October 29, 2015

  ABSTRACT: Recently studies found that TRPC3 and TRPC6 played an important role in cardiovascular disease. Hypertension, as a cardiovascular disease causing the highest morbidity and mortality, has close relationship with the expressions of TRPC3 and TRPC6. Unbalanced calcium homeostasis is the major factor of pathogenesis of hypertension. Changes of intracellular calcium concentration depend on calcium transmembrane transportation, intracellular calcium store releasing and other processes. TRPC3, TRPC6 molecules, as non-selective cation channels on the cell membranes, are involved in the processes. This review illustrated the functions of TRPC3 and TRPC6 on myocardial cells, smooth muscle cells and inflammatory cells in the development of hypertension, and the effects of drugs like sildenafil to provide a new way for the prevention and treatment of hypertension.